ERIC BJERKHOLT - 10 May 2024 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Judit Ryvkin, Attorney-in-Fact
Issuer symbol
MIRM
Transactions as of
10 May 2024
Net transactions value
+$9,892
Form type
4
Filing time
16 May 2024, 16:30:48 UTC
Previous filing
22 Apr 2024
Next filing
06 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common Stock Award $9,892 +470 +3.4% $21.05 14,470 10 May 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 is being filed voluntarily to report the acquisition of 470 shares by the Reporting Person on May 10, 2024 pursuant to the Issuer's Employee Stock Purchase Plan.